Zag Bio

Zag Bio, headquartered in San Francisco, California, is a biotechnology company pioneering a novel approach to cancer treatment through the development of engineered bacteria-based therapeutics. The company is advancing a platform technology that utilizes genetically modified bacteria to selectively target and destroy solid tumors while simultaneou... sly activating the immune system to recognize and attack cancer cells. Zag Bio's lead therapeutic candidate is designed to address the significant challenge of treating solid tumors, which account for the majority of cancer cases but have proven difficult to treat with traditional immunotherapies. The company's engineered bacteria are programmed to colonize the tumor microenvironment, where they release therapeutic payloads directly at the tumor site while minimizing systemic exposure and potential side effects. This localized delivery approach aims to overcome the limitations of conventional cancer treatments by combining direct tumor cell killing with immune system activation, creating a dual mechanism of action. Zag Bio's technology platform represents a new frontier in oncology, leveraging synthetic biology and microbial engineering to create living therapeutics that can adapt and respond to the tumor environment. The company is focused on advancing its lead programs through preclinical development toward clinical trials, with the goal of providing new treatment options for patients with hard-to-treat solid tumors where current therapies have limited efficacy.Read More